Harmony Biosciences Holdings, Inc. HRMY Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $215.39M+16.6% | $243.78M+21.1% | $239.46M+28.7% | $200.49M+16.0% | $184.73M+19.5% | ||
| $44.51M+39.1% | $68.55M+26.0% | $59.65M+39.4% | $38.15M+18.7% | $31.99M+16.4% | ||
| $170.88M+11.9% | $175.23M+19.3% | $179.81M+25.5% | $162.34M+15.4% | $152.74M+20.1% | ||
| 79.3%-3.3pp | 71.9%-1.1pp | 75.1%-1.9pp | 81%-0.4pp | 82.7%+0.5pp | ||
| $69.38M+101% | $49.93M+44.0% | $54.96M+116% | $50.16M-21.1% | $34.54M+55.7% | ||
| $31.69M+3.2% | $29.18M+5.7% | $29.55M+7.2% | $30.07M+5.5% | $30.71M+12.8% | ||
| $32.51M+4.0% | $57.56M+99.4% | $29.81M+4.3% | $33.92M+24.6% | $31.24M+21.7% | ||
| $133.58M+38.4% | $136.67M+50.0% | $114.32M+40.2% | $114.16M-4.3% | $96.49M+28.5% | ||
| $133.58M+38.4% | $136.67M+50.0% | $114.32M+40.2% | $114.16M-4.3% | $96.49M+28.5% | ||
| $37.29M-33.7% | $38.56M-30.8% | $65.49M+6.1% | $48.18M+126% | $56.25M+8.1% | ||
| 17.3%-13.1pp | 15.8%-11.9pp | 27.3%-5.8pp | 24%+11.7pp | 30.4%-3.2pp | ||
| $3.23M-15.7% | $3.55M-15.8% | $3.62M-16.7% | $3.65M-17.2% | $3.84M-15.4% | ||
| -$127K+54.0% | -$105K— | -$106K+14.5% | -$193K-622% | -$276K-95.7% | ||
| $39.69M-30.6% | $40.76M-27.4% | $67.49M+8.6% | $49.64M+129% | $57.18M+10.4% | ||
| $7.2M-38.0% | $18.27M+174% | $16.63M+3.4% | $9.86M-2.4% | $11.62M-13.6% | ||
| $32.49M-28.7% | $22.49M-54.6% | $50.87M+10.4% | $39.78M+243% | $45.56M+18.9% | ||
| 15.1%-9.6pp | 9.2%-15.4pp | 21.2%-3.5pp | 19.8%+13.1pp | 24.7%-0.1pp | ||
| $0.55-29.5% | $0.39-54.1% | $0.87+10.1% | $0.68+240% | $0.78+16.4% | ||
| $0.56-29.1% | $0.40-54.0% | $0.88+8.6% | $0.69+245% | $0.79+16.2% | ||
| 58.8M+0.4% | 58.5M+1.2% | 58.7M+1.1% | 58.4M+1.5% | 58.5M+1.6% | ||
| 57.8M+0.9% | 57.5M+1.1% | 57.6M+1.2% | 57.5M+1.2% | 57.3M+0.9% | ||
| $31.73M-30.6% | $22.48M-54.2% | $50.98M+8.9% | $39.77M+245% | $45.74M+19.9% | ||
| $5.76M+14.1% | $5.85M+30.8% | $5.73M+16.2% | $5.3M+12.6% | $5.04M+13.9% | ||
| -$127K+54.0% | -$105K— | -$106K+14.5% | -$193K-622% | -$276K-95.7% | ||
| $215.39M+16.6% | $243.78M+21.1% | $239.46M+28.7% | $200.49M+16.0% | $184.73M+19.5% | ||
| $37.29M-33.7% | $38.56M-30.8% | $65.49M+6.1% | $48.18M+126% | $56.25M+8.1% | ||
| $43.26M-30.5% | $44.52M-27.8% | $71.46M+5.6% | $54.15M+97.6% | $62.21M+7.0% | ||
| $43.26M-30.5% | $44.52M-27.8% | $71.46M+5.6% | $54.15M+97.6% | $62.21M+7.0% | ||
| 20.1%-13.6pp | 18.3%-12.4pp | 29.8%-6.5pp | 27%+11.1pp | 33.7%-3.9pp | ||
| $37.29M-33.7% | $38.56M-30.8% | $65.49M+6.1% | $48.18M+126% | $56.25M+8.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Harmony Biosciences Holdings, Inc.'s profit margins?
- Gross margin is 76.5% and operating margin is 21.1%, with a 16.2% net margin.
- Where does Harmony Biosciences Holdings, Inc.'s income statement data come from?
- Every line is extracted from Harmony Biosciences Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.